Evidence map›Paper›PMID 36961044›Full record

ReviewMethods and protocols2023

Tn5 DNA Transposase in Multi-Omics Research.

Dmitry Penkov, Ekaterina Zubkova, Yelena Parfyonova

Full text readReview
In one paragraph

Review in Methods and protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Uncovering virulence factors inApplied and environmental microbiology · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dmitry PenkovIRCCS San Raffaele Hospital, 20132 Milan, Italy.ORCID 0000-0002-3741-1060
Ekaterina ZubkovaNational Medical Research Centre of Cardiology Named after E. I. Chazov, 121552 Moscow, Russia.ORCID 0000-0002-0512-3670
Yelena ParfyonovaNational Medical Research Centre of Cardiology Named after E. I. Chazov, 121552 Moscow, Russia.

Funding

Russian Foundation for Basic Research 19-29-04112
6 · The paper itself

Abstract

Tn5 transposase use in biotechnology has substantially advanced the sequencing applications of genome-wide analysis of cells. This is mainly due to the ability of Tn5 transposase to efficiently transpose DNA essentially randomly into any target DNA without the aid of other factors. This concise review is focused on the advances in Tn5 applications in multi-omics technologies, genome-wide profiling, and Tn5 hybrid molecule creation. The possibilities of other transposase uses are also discussed.

Indexed as

CUT&TagomicstagmentationTn5 transposase

Identifiers

PMID36961044
PMCPMC10037646

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read5
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.